Evidence map›Paper›PMID 42370609›Full record

Observational studyEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026

Catheter ablation of atrial fibrillation in transthyretin and light-chain cardiac amyloidosis: results from the multicentre AMYL-AF study.

Daniele Faccenda, Marco Bergonti, Tom De Potter, Michel Haïssaguerre, Johan Saenen, Carlo De Asmundis, Giuseppe Ciconte, Marta De Riva, Michela Casella, Jacopo Costantino and 33 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Daniele FaccendaCardiology Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete 48, Lugano CH-6900, Switzerland.ORCID 0009-0007-5159-2500
Marco BergontiCardiology Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete 48, Lugano CH-6900, Switzerland.ORCID 0000-0001-9864-1938
Tom De PotterCardiovascular Center, AZORG Hospital, Aalst, Belgium.ORCID 0000-0003-1424-114X
Michel HaïssaguerreHôpital Cardiologique du Haut-Lévêque, CHU Bordeaux, L'Institut de Rythmologie et Modélisation Cardiaque (LIRYC), Université Bordeaux, Bordeaux, France.ORCID 0000-0001-7644-6146
Johan SaenenDepartment of Cardiology, University Hospital Antwerp, Edegem, Belgium.ORCID 0000-0002-0049-4632
Carlo De AsmundisHeart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.ORCID 0000-0001-9351-0760
Giuseppe CiconteArrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, Milano, Italy.ORCID 0000-0001-7886-5467
Marta De RivaDepartment of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0002-5878-6750
Michela CasellaCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Ancona, Italy.ORCID 0000-0002-5322-1742
Jacopo CostantinoDepartment of Clinical, Internal, Anaesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.ORCID 0009-0000-4869-4898
Daniel ScherrDivision of Cardiology, Medical University Graz, Graz, Austria.ORCID 0000-0001-5868-5493
Mikael LaredoInstitut de Cardiologie, Hôpital Universitaire Pitié-Salpêtriere, AP-HP, Sorbonne Université, Paris, France.ORCID 0000-0002-7326-2656
Patrizio MazzoneCardiac Arrhythmia Department, Great Metropolitan Hospital Niguarda, Milan, Italy.ORCID 0000-0001-5775-1874
Avi SabbagThe Davidai Center for Rhythm Disturbances and Pacing, Chaim Sheba Medical Center, Tel Hashomer and the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.ORCID 0000-0003-4295-6679
Matteo AnselminoDivision of Cardiology, Cardiovascular and Thoracic Department, Città Della Salute e Della Scienza di Torino Hospital, Turin - Department of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-6311-4270
Andrea RossiArrhythmology Division, Fondazione Gabriele Monasterio CNR-Regione Toscana, via Giuseppe Moruzzi, Pisa, Italy.ORCID 0000-0003-4430-6821
Matteo BertiniDepartment of Translational Medicine, Cardiology Unit, Sant'Anna University Hospital, University of Ferrara, Ferrara, Italy.ORCID 0000-0002-5285-7140
Lia CrottiDepartment of Cardiology, IRCCS, Istituto Auxologico Italiano, San Luca Hospital, Cardiomyopathy Unit, Milan, Italy.ORCID 0000-0001-8739-6527
Christian-Hendrik HeegerDepartment of Rhythmology, Cardiology and Internal Medicine, Asklepios Klinik Hamburg Altona Hamburg, Hamburg, Germany.ORCID 0000-0002-9014-8097
Claudio TondoDepartment of Clinical Electrophysiology and Cardiac Pacing, Centro Cardiologico Monzino IRCCS, Milan, Italy.ORCID 0000-0002-8500-8313
Elena ArbeloArrhythmia Section, Cardiology Department, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0003-0424-6393
Moises LevinsteinDepartment of Electrophysiology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Sebastiaan R D PiersDepartment of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0002-5463-6384
Maria L CaputoCardiology Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete 48, Lugano CH-6900, Switzerland.ORCID 0000-0003-1190-5967
Carlo PapponeArrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, Milano, Italy.ORCID 0000-0002-0901-6135
Domenico G Della RoccaHeart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.ORCID 0000-0003-3837-3462
Olivier Van LeuvenDepartment of Cardiology, University Hospital Antwerp, Edegem, Belgium.ORCID 0000-0003-4246-9707
Paolo CompagnucciCardiology and Arrhythmology Clinic, University Hospital 'Ospedali Riuniti', Ancona, Italy.ORCID 0000-0003-1924-6548
Tardu ÖzkartalCardiology Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete 48, Lugano CH-6900, Switzerland.ORCID 0000-0001-8391-8164
Raffaele SalernoArrhythmia and Electrophysiology Department, IRCCS Policlinico San Donato, Piazza E. Malan 1, San Donato Milanese, Milano, Italy.ORCID 0009-0009-8433-692X
Chiara PavoneInstitut de Cardiologie, Hôpital Universitaire Pitié-Salpêtriere, AP-HP, Sorbonne Université, Paris, France.ORCID 0000-0002-6837-6800
Valeria RellaDepartment of Cardiology, IRCCS, Istituto Auxologico Italiano, San Luca Hospital, Cardiomyopathy Unit, Milan, Italy.ORCID 0000-0001-8485-3649
Katharina I GöllyDivision of Cardiology, Medical University Graz, Graz, Austria.ORCID 0009-0004-6157-0717
Lorenzo GigliCardiac Arrhythmia Department, Great Metropolitan Hospital Niguarda, Milan, Italy.
Cristina BallaDepartment of Translational Medicine, Cardiology Unit, Sant'Anna University Hospital, University of Ferrara, Ferrara, Italy.ORCID 0000-0003-2110-8961
Cristina ChimentiDepartment of Clinical, Internal, Anaesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.ORCID 0000-0001-5954-3796
Nicolas JohnerHôpital Cardiologique du Haut-Lévêque, CHU Bordeaux, L'Institut de Rythmologie et Modélisation Cardiaque (LIRYC), Université Bordeaux, Bordeaux, France.ORCID 0000-0001-8236-1165
Alessandro LascheraCardiovascular Center, AZORG Hospital, Aalst, Belgium.
Manuela AveraimoCardiology Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete 48, Lugano CH-6900, Switzerland.
Esther ScheirlynckCardiology Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete 48, Lugano CH-6900, Switzerland.ORCID 0000-0002-3816-2166
Marco SchiavoneDepartment of Clinical Electrophysiology and Cardiac Pacing, Centro Cardiologico Monzino IRCCS, Milan, Italy.ORCID 0000-0003-0720-3380
Cinzia MonacoHôpital Cardiologique du Haut-Lévêque, CHU Bordeaux, L'Institut de Rythmologie et Modélisation Cardiaque (LIRYC), Université Bordeaux, Bordeaux, France.ORCID 0000-0002-5373-1689
Giulio ConteCardiology Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete 48, Lugano CH-6900, Switzerland.ORCID 0000-0003-2248-3456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsAtrial fibrillation (AF) is highly prevalent among cardiac amyloidosis (CA) patients and contributes significantly to their morbidity and mortality. Evidence regarding AF ablation efficacy and safety in CA patients remains limited. The aim of our study is to evaluate baseline characteristics, clinical course and outcomes of AF ablation in a series of patients with transthyretin (ATTR) or light-chain (AL) CA from a multicentre international registry. METHODS AND

resultsPatients with CA who underwent AF ablation were included. Co-primary endpoints were: (i) atrial arrhythmia (AA) recurrence; (ii) a composite endpoint of all-cause mortality and heart failure hospitalization (HFH). 109 patients (mean age 72.4 ± 7.4 years, females 17.4%, persistent AF 64.2%, ATTR 78%, AL 22%) were included. Radiofrequency, cryo-balloon and pulsed-field ablation were performed in 67%, 15% and 18% of patients, respectively; 49.5% received pulmonary vein isolation plus additional ablations. Low voltage zones were documented in 34 out of 44 patients undergoing electro-anatomical mapping (77.3%). During a median follow-up of 22.7 months, 63 patients (58.3%) experienced AA recurrence (32.4% persistent AF recurrence), with no significant differences between CA subtypes (ATTR 59.5% vs. AL 54.2%, log-rank P = 0.55). The composite endpoint of HFH and all-cause death occurred in 27 patients (25%). Recurrence of persistent AF was associated with three-fold higher risk (OR 2.9, P = 0.02) of the composite endpoint.

conclusionCA patients undergoing AF ablation present high prevalence of persistent AF. Freedom from AA after AF ablation is achieved in 42% of patients after a two-year follow-up. Patients with persistent AF recurrence have a three-fold higher risk of HFH and death.

Indexed as

Amyloid Neuropathies, FamilialAtrial FibrillationCardiomyopathiesCatheter AblationImmunoglobulin Light-chain AmyloidosisPulmonary VeinsAgedFemaleHumansMaleRecurrenceRegistriesRisk FactorsTime FactorsTreatment OutcomeAblationAtrial fibrillationCardiac amyloidosisPulmonary vein isolation

Identifiers

PMID42370609
PMCPMC13312283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.